This Largecap Pharma Stock’s Sales Grew Rs. 52.2bn, ‘Buy’: Prabhudas Lilladher


Reputed brokerage firm Prabhudas Lilladher recommends investors to buy the stocks of Dr. Reddy’s Laboratories. The company’s sales grew 6% YoY at Rs. 52.2bn. Its resultant PAT came in at Rs. 11.9bn; higher than the brokerage firm’s estimate. Interest income also